碳水化合物-乳素相互作用 重新编程树突细胞以促进 1 型抗瘤免疫力
Valerie Lensch1, Adele Gabba1, Robert Hincapie2
1Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
ACS nano
|September 16, 2024
概括
具有特定甘氨酸涂层和通用类似受体 (TLR) 激动剂的工程病毒样粒子 (VLP) 疫苗通过重编程树突细胞 (DC) 有效诱导强大的抗瘤细胞免疫力. 这种方法显著抑制瘤生长,并提供预防癌症复发的保护.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 在瘤学瘤学.
背景情况:
- 癌症疫苗的开发需要策略来诱导瘤特异性细胞免疫.
- 通过莱克和收费类受体 (TLRs) 激活树突细胞 (DC) 塑造免疫反应.
- 识别驱动1型细胞免疫力的受体对于有效的疫苗至关重要.
研究的目的:
- 设计一种类似病毒的粒子 (VLP) 疫苗,能够指导树突细胞 (DC) 激活,从而产生强大的1型细胞免疫力.
- 利用涉及DC讲解蛋白和TLR的双信号通路,以提高癌症疫苗的疗效.
- 在小鼠黑色素瘤模型中评估一种新型的用甘氨酸修饰的VLP疫苗的治疗潜力.
主要方法:
- 工程化甘氨酸装饰的VLP显示DC-SIGN选择性连接体,并封装TLR7激动剂.
- 将可编程的抗原传递给DC进行激活.
- 在小鼠黑色素瘤模型中评估了T细胞反应 (CD4 +,CD8 +),瘤透,瘤生长抑制,以及对瘤重新引入的保护.
主要成果:
- 穿着甘氨酸的VLP诱导了强大的DC激活和1型细胞免疫,产生瘤抗原特异的Th1 CD4+和CD8+T细胞.
- 用量身定制的VLP接种疫苗在小鼠黑色素瘤模型中显著抑制了瘤生长.
- 缺乏DC-SIGN连接体的VLP促进了具有有限瘤控制的幽默免疫力,突出显示了糖伪装方法的重要性.
结论:
- 使用工程VLPs进行DC莱克驱动的免疫重编程是癌症疫苗开发的一个有希望的策略.
- VLP平台的模块化可编程性允许定制免疫反应.
- 这种方法为通过引导细胞免疫力来推进癌症免疫疗法和疫苗提供了一个框架.
相关概念视频
01:22T Cell Activation and Clonal Selection
688
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
688
01:26Antigens Involved in Adaptive Immunity
474
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
474
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
01:40Cell-mediated Immune Responses
67.8K
Overview
67.8K
01:24T Cell Types and Functions
961
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
961
01:25Selectins
3.3K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K